Chimerix Stock Five Year Return

CMRX Stock

USD 0.91 0.01 0.56%

Chimerix fundamentals help investors to digest information that contributes to Chimerix's financial success or failures. It also enables traders to predict the movement of Chimerix Stock. The fundamental analysis module provides a way to measure Chimerix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Chimerix stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Chimerix Company Five Year Return Analysis

Chimerix's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.

Five Year Return

(Mean of Monthly Returns - 1)

X

100%

More About Five Year Return | All Equity Analysis

Chimerix Five Year Return Driver Correlations

Understanding the fundamental principles of building solid financial models for Chimerix is extremely important. It helps to project a fair market value of Chimerix Stock properly, considering its historical fundamentals such as Five Year Return. Since Chimerix's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Chimerix's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Chimerix's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Current Deferred Revenue	Long Term Investments	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		1.0	-0.33	-0.25	0.61	-0.58	-0.25	0.91	0.06	0.97	-0.22	0.45	0.5	0.94	-0.11	0.54	-0.53	0.42	-0.14	0.34	0.41	0.1
Total Stockholder Equity	1.0		-0.35	-0.24	0.6	-0.58	-0.25	0.91	0.01	0.97	-0.26	0.43	0.49	0.94	-0.11	0.53	-0.52	0.42	-0.15	0.34	0.42	0.07
Net Debt	-0.33	-0.35		-0.22	-0.12	0.13	0.49	0.0	0.31	-0.44	0.0	0.08	0.04	-0.25	-0.1	0.08	-0.28	0.04	0.11	-0.17	-0.19	0.34
Retained Earnings	-0.25	-0.24	-0.22		0.28	0.6	0.48	-0.47	-0.3	-0.34	-0.14	-0.93	-0.03	-0.02	0.41	-0.92	0.85	0.56	-0.79	0.61	0.19	-0.81
Accounts Payable	0.61	0.6	-0.12	0.28		-0.3	0.32	0.47	0.13	0.47	-0.19	-0.16	0.61	0.69	0.14	-0.03	-0.07	0.7	-0.47	0.38	0.23	-0.34
Long Term Debt	-0.58	-0.58	0.13	0.6	-0.3		0.04	-0.62	-0.01	-0.6	0.21	-0.57	-0.33	-0.43	0.18	-0.7	0.66	0.14	-0.29	0.26	0.04	-0.33
Net Receivables	-0.25	-0.25	0.49	0.48	0.32	0.04		-0.15	-0.12	-0.39	-0.43	-0.58	0.04	-0.02	0.11	-0.46	0.28	0.43	-0.42	0.36	0.14	-0.29
Short Term Investments	0.91	0.91	0.0	-0.47	0.47	-0.62	-0.15		0.13	0.89	-0.26	0.62	0.48	0.87	-0.17	0.71	-0.75	0.27	0.05	0.22	0.4	0.32
Total Liab	0.06	0.01	0.31	-0.3	0.13	-0.01	-0.12	0.13		0.03	0.7	0.39	0.24	0.01	-0.14	0.31	-0.14	0.06	0.24	-0.07	-0.08	0.62
Total Current Assets	0.97	0.97	-0.44	-0.34	0.47	-0.6	-0.39	0.89	0.03		-0.18	0.54	0.41	0.88	-0.15	0.61	-0.55	0.21	0.02	0.27	0.44	0.18
Short Term Debt	-0.22	-0.26	0.0	-0.14	-0.19	0.21	-0.43	-0.26	0.7	-0.18		0.21	0.27	-0.35	0.15	0.05	0.1	-0.23	0.11	-0.34	-0.48	0.28
Common Stock	0.45	0.43	0.08	-0.93	-0.16	-0.57	-0.58	0.62	0.39	0.54	0.21		0.1	0.25	-0.26	0.96	-0.81	-0.41	0.67	-0.42	-0.05	0.81
Property Plant Equipment	0.5	0.49	0.04	-0.03	0.61	-0.33	0.04	0.48	0.24	0.41	0.27	0.1		0.48	0.31	0.16	-0.36	0.38	-0.48	0.0	-0.23	-0.21
Net Tangible Assets	0.94	0.94	-0.25	-0.02	0.69	-0.43	-0.02	0.87	0.01	0.88	-0.35	0.25	0.48		-0.03	0.37	-0.36	0.57	-0.31	0.55	0.55	-0.04
Long Term Debt Total	-0.11	-0.11	-0.1	0.41	0.14	0.18	0.11	-0.17	-0.14	-0.15	0.15	-0.26	0.31	-0.03		-0.33	0.27	0.13	-0.5	0.06	-0.17	-0.52
Capital Surpluse	0.54	0.53	0.08	-0.92	-0.03	-0.7	-0.46	0.71	0.31	0.61	0.05	0.96	0.16	0.37	-0.33		-0.84	-0.36	0.63	-0.38	0.0	0.75
Current Deferred Revenue	-0.53	-0.52	-0.28	0.85	-0.07	0.66	0.28	-0.75	-0.14	-0.55	0.1	-0.81	-0.36	-0.36	0.27	-0.84		0.22	-0.45	0.35	0.0	-0.54
Long Term Investments	0.42	0.42	0.04	0.56	0.7	0.14	0.43	0.27	0.06	0.21	-0.23	-0.41	0.38	0.57	0.13	-0.36	0.22		-0.78	0.72	0.35	-0.41
Short Long Term Debt	-0.14	-0.15	0.11	-0.79	-0.47	-0.29	-0.42	0.05	0.24	0.02	0.11	0.67	-0.48	-0.31	-0.5	0.63	-0.45	-0.78		-0.58	-0.07	0.78
Net Invested Capital	0.34	0.34	-0.17	0.61	0.38	0.26	0.36	0.22	-0.07	0.27	-0.34	-0.42	0.0	0.55	0.06	-0.38	0.35	0.72	-0.58		0.82	-0.32
Net Working Capital	0.41	0.42	-0.19	0.19	0.23	0.04	0.14	0.4	-0.08	0.44	-0.48	-0.05	-0.23	0.55	-0.17	0.0	0.0	0.35	-0.07	0.82		0.02
Capital Stock	0.1	0.07	0.34	-0.81	-0.34	-0.33	-0.29	0.32	0.62	0.18	0.28	0.81	-0.21	-0.04	-0.52	0.75	-0.54	-0.41	0.78	-0.32	0.02

Click cells to compare fundamentals

Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.

Competition

Predict Chimerix

Chimerix Return On Tangible Assets

Return On Tangible Assets

(0.41)

At this time, Chimerix's Return On Tangible Assets are fairly stable compared to the past year.

According to the company disclosure, Chimerix has a Five Year Return of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Chimerix Five Year Return Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chimerix's direct or indirect competition against its Five Year Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Chimerix could also be used in its relative valuation, which is a method of valuing Chimerix by comparing valuation metrics of similar companies.

Chimerix is currently under evaluation in five year return category among its peers.

Chimerix Current Valuation Drivers

We derive many important indicators used in calculating different scores of Chimerix from analyzing Chimerix's financial statements. These drivers represent accounts that assess Chimerix's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Chimerix's important valuation drivers and their relationship over time.

	2019	2020	2021	2022	2023	2024 (projected)
Market Cap	112.7M	300.3M	546.1M	162.9M	85.3M	81.0M
Enterprise Value	96.0M	256.2M	547.1M	139.1M	58.9M	56.0M

Chimerix Fundamentals

	Return On Equity	-0.49
	Return On Asset	-0.3
	Operating Margin	(953.58) %
	Current Valuation	(54.27 M)
	Shares Outstanding	89.94 M
	Shares Owned By Insiders	6.62 %
	Shares Owned By Institutions	45.90 %
	Number Of Shares Shorted	1.52 M
	Price To Earning	(3.43) X
	Price To Book	0.60 X
	Price To Sales	511.39 X
	Revenue	324 K
	Gross Profit	(36.49 M)
	EBITDA	(92.97 M)
	Net Income	(82.09 M)
	Cash And Equivalents	42.79 M
	Cash Per Share	0.49 X
	Total Debt	1.3 M
	Debt To Equity	0.1 %
	Current Ratio	2.18 X
	Book Value Per Share	1.51 X
	Cash Flow From Operations	(69.09 M)
	Short Ratio	2.74 X
	Earnings Per Share	(0.94) X
	Target Price	7.0
	Number Of Employees	72
	Beta	1.13
	Market Capitalization	81.31 M
	Total Asset	212.77 M
	Retained Earnings	(795.52 M)
	Working Capital	170.67 M
	Current Asset	228.84 M
	Current Liabilities	20.18 M
	Net Asset	212.77 M

About Chimerix Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Chimerix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chimerix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chimerix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for Chimerix Stock Analysis

When running Chimerix's price analysis, check to measure Chimerix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chimerix is operating at the current time. Most of Chimerix's value examination focuses on studying past and present price action to predict the probability of Chimerix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chimerix's price. Additionally, you may evaluate how the addition of Chimerix to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC